Figure 5
The reversible, covalent inhibition mechanism of 3CLpro by isatin-based inhibitors. (a) The reversible covalent-bond formation between an isatin and Cys145. (b) A surface plasmon resonance sensorgram showing the rapidly reversible binding of cpd-28 and cpd-29. 6-Chlorochroman-4-carboxylic acid isoquinolin-4-ylamide was used at 1.25 µM as a positive control, and running buffer containing no 3CLpro fragment was used as a negative control. |